These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32528400)

  • 21. Fingolimod Affects Transcription of Genes Encoding Enzymes of Ceramide Metabolism in Animal Model of Alzheimer's Disease.
    Jęśko H; Wencel PL; Wójtowicz S; Strosznajder J; Lukiw WJ; Strosznajder RP
    Mol Neurobiol; 2020 Jun; 57(6):2799-2811. PubMed ID: 32356173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of sphingolipid metabolism in neurodegeneration.
    Alaamery M; Albesher N; Aljawini N; Alsuwailm M; Massadeh S; Wheeler MA; Chao CC; Quintana FJ
    J Neurochem; 2021 Jul; 158(1):25-35. PubMed ID: 32402091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of sphingolipid-mediated cell death in neurodegenerative diseases.
    Ariga T; Jarvis WD; Yu RK
    J Lipid Res; 1998 Jan; 39(1):1-16. PubMed ID: 9469581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets.
    Custodia A; Aramburu-Núñez M; Correa-Paz C; Posado-Fernández A; Gómez-Larrauri A; Castillo J; Gómez-Muñoz A; Sobrino T; Ouro A
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
    Angelopoulou E; Piperi C
    Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy.
    Lee JY; Jin HK; Bae JS
    BMB Rep; 2020 Jan; 53(1):28-34. PubMed ID: 31818364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview of sphingolipid metabolism: from synthesis to breakdown.
    Gault CR; Obeid LM; Hannun YA
    Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceramidases, roles in sphingolipid metabolism and in health and disease.
    Coant N; Sakamoto W; Mao C; Hannun YA
    Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurodegenerative Disorders: Spotlight on Sphingolipids.
    Mandik F; Vos M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
    Blanz J; Saftig P
    J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingolipids in neurodegeneration.
    Haughey NJ
    Neuromolecular Med; 2010 Dec; 12(4):301-5. PubMed ID: 20737248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sphingolipids as critical players in retinal physiology and pathology.
    Simon MV; Basu SK; Qaladize B; Grambergs R; Rotstein NP; Mandal N
    J Lipid Res; 2021; 62():100037. PubMed ID: 32948663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine kinase 1/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson's disease.
    Motyl J; Strosznajder JB
    Pharmacol Rep; 2018 Oct; 70(5):1010-1014. PubMed ID: 30138818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates on sphingolipids: Spotlight on retinopathy.
    Shiwani HA; Elfaki MY; Memon D; Ali S; Aziz A; Egom EE
    Biomed Pharmacother; 2021 Nov; 143():112197. PubMed ID: 34560541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer's Disease.
    Qi YY; Heng X; Yao ZY; Qu SY; Ge PY; Zhao X; Ni SJ; Guo R; Yang NY; Zhang QC; Zhu HX
    Drug Des Devel Ther; 2022; 16():931-950. PubMed ID: 35391788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.
    Taguchi YV; Liu J; Ruan J; Pacheco J; Zhang X; Abbasi J; Keutzer J; Mistry PK; Chandra SS
    J Neurosci; 2017 Oct; 37(40):9617-9631. PubMed ID: 28847804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases.
    Pujol-Lereis LM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of bioactive sphingolipids in physiology and pathology.
    Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
    Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma sphingolipid abnormalities in neurodegenerative diseases.
    Oizumi H; Sugimura Y; Totsune T; Kawasaki I; Ohshiro S; Baba T; Kimpara T; Sakuma H; Hasegawa T; Kawahata I; Fukunaga K; Takeda A
    PLoS One; 2022; 17(12):e0279315. PubMed ID: 36525454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.